Clinical trial
An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With…
NCT00365560 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00365560 |
|---|---|
| Title | An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent Asthma |
| Official title | A Randomised, Double-Blind, Placebo-Controlled, Crossover Efficacy and Safety Evaluation of 8-Week Treatment Periods of Two Doses [5 Mcg (2 Actuations of 2.5 Mcg) and 10 Mcg (2 Actuations of 5 Mcg)] of Tiotropium Inhalation Solution Delivered by the Respimat Inhaler® as Add-on Therapy in Patients… |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | tiotropium, placebo |
| Enrollment | 115 |
| Start date | Aug 1, 2006 |
| Primary completion | Nov 1, 2007 |
| First posted | Aug 17, 2006 |
| Last update posted | Jul 11, 2013 |
| Countries | Denmark, Germany, Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: